The effect of anti-CD3-immunotoxin on T lymphocyte function in vitro

Transplant Immunology

Volumn 6, Issue 1, 1998, Pages 53-59

  Meng, Gang ^a   Jiang, Yi ^a   Hubbard, William ^a   Thomas, Judith M ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Division of Immunology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXOID; GAMMA INTERFERON; IMMUNOTOXIN; INTERLEUKIN 2; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL KILLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MACACA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032030264     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(98)80035-X     Document Type: Article

References (29)

1. Thomas JM, Thomas FT. Strategies for developing organ transplant tolerance. Minerva Chirurgica. 46:1991;51-55.
2. Lafferty K. A contemporary view of transplant tolerance: an immunologist's perspective. Clin Transplantation. 8:1994;181-189.
3. Thomas JM, Thomas FT. A preclinical view of transplant tolerance and chimerism: tolerance induction by postransplant lymphoid irradiation and donor bone marrow. Ilstad S. Chimerism and tolerance. 143-158:1995;Springer, Heidelberg.
4. Nikolic B, Sykes M. Clonal detection as a mechanism of transplantation tolerance [Review]. J Heart Lung Transplantation. 15:1996;1171-1178.
5. Thomas JM, Verbanac KM. Tolerance induction: basis concepts and therapeutic approaches. Lieberman R, Mukherjee A. Principles of drug development in transplantation and autoimmunity. 59-79:1996;Landes.
6. Knechtle SJ, Vargo D, Fechner J, et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation. 63:1997;1-6.
7. Sharabi Y, Abraham VS, Sykes M, Sachs DH. Mixed allogeneic chimeras prepared by a non-mycloablative regimen: requirement for chimerism to maintain tolerance. Bone Marrow Transplantation. 9:1992;191-197.
8. Moses RD, Sharrow SO, Stephany DA, Orr KS, Gress RE. Cardiac allograft survival across major histocompatibility complex barriers in the rhesus monkey following T lymphocyte-depleted autologous marrow transplantation. Transplantation. 48:1989;774-781.
9. Myburgh JA, Smit JA, Hill RRH, Browde S. Transplantation tolerance in primates following total lymphoid irradiation and allogenic bone marrow injection. II. Renal Allografts. Transplantation. 29:1980;405-408.
10. Thomas JM, Carver M, Cunningham P, Sash C, Park K, Thomas F. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant an tithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs. Transplantation. 47:1989;209-215.
11. Kawai T, Cosimi AB, Powelson J, et al. Multilineage mixed chimerism and transplantation tolerance in cynomolgus monkeys [Abstract]. Am Soc Transplant Surg. 1:1994;31.
12. Thomas JM, Carver FM, Kasten-Jolly J, Haisch CE, Thomas FT. Transplantation tolerance in nonhuman primates: a case for vetocells. Transplantation Science. 3:1989;69-71.
13. Carver FM, Alqaisi M, Cunningham P, Gross U, Thomas F, Thomas J. Post-transplant TLI is effective in nonhuman primates if combined with rabbit ATG. Transplant Proc. 23:1991;480-481.
14. Thomas JM, Carver FM, Cunningham PRG, Olson LC, Thomas FT. Kidney allograph tolerance in primates without chronic immunosuppression: The role of veto cells. Transplantation. 51:1991;198-207.
15. Thomas J, Alqaisi M, Cunningham P, et al. The development of a posttransplant TLI treatment strategy that promotes organ allograft acceptance without chronic immunosuppression. Transplantation. 53:1992;247-258.
16. Preclinical studies of allograft tolerance in rhesus monkeys Thomas JM, Neville DM Jr, Contreras JL, et al. A novel anti-CD3 immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts. Transplantation. 64:1997;124-135.
17. Ildstad S, Wren S, Bluestone J, Barbieri S, Stephany D, Sachs D. Effect of Selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogenic chimeras (B10 + B10.D2-B10). J Immunol. 136:1986;28-33.
18. Neville DM Jr, Scharff J, Hu Hz, et al. A new reagent for the induction of T-cell depletion, antiCD3-CRM9. J Immunotherapy Emph Tummor Immunol. 19:1996;85-92.
19. Neville DM Jr, Scharff J, Srinivasachar K. Anti-T cell immunotoxins. A look at post-endocytic receptor-mediated routing. J Controlled Release. 24:1995;133-141.
20. Wawrzynczak EJ, Derbyshire EJ. Immunotoxins: the power and the glory. Immunol Today. 13:1992;381-383.
21. Wu M. Enhancement of immunotoxin activity using chemical and biological reagents [Review]. Br J Cancer. 75:1997;1347-1355.
22. Chen SY, Marasco WA. Novel genetic immunotoxins and intracellular antibodies for cancer therapy [Review]. Semin Oncol. 23:1996;148-153.
23. Ghetie MA, Vitetta ES. Recent developments in immunotoxin therapy [Review]. Current Opin Immunol. 6:1994;707-714.
24. Fechnet JH Jr, Vargo DJ, Geissler EK, et al. Split tolerance induced by immunotoxin in a rhesus kidney allograft model. Transplantation. 63:1997;1339-1345.
25. Nooij FJ, Jonker M. The effect of skin allograft survival of a monoclonal antibody specific for a polymorphic CD3-like cell surface molecule in rhesus monkeys. Eur J Immunol. 17:1987;1089-1093.
26. Nooij FJ, van Vreeswijk W, Collen J. Polymorphism for RhT3 a CD-3 like cell surface antigen, expressed on rhesus monkey T lymphocytes. Immunology. 59:1986;611-620.
27. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immmunol. 150:1993;3671-3680.
28. Grabstein KH, Maliszewski CR, Shanebeck K, et al. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J Immunol. 150:1993;3141-3147.
29. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA. 93:1996;13967-13972.